Severe obstructive disease: Similarities and differences between smoker and non-smoker patients with COPD and/or bronchiectasis

Revista Portuguesa de Pneumologia

Volumn 19, Issue 1, 2013, Pages 13-18

  Rezende Goncalves J ^a   Corso Pereira, M ^a   Figueiras Pedreira De Cerqueira, E M ^a   Oliveira Magro, D ^a   Mello Moreira, M ^a   Paschoal, I A ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Airway obstruction; Bronchiectasis; Bronchitis; Bronchodilator tests; Computed tomography of the thorax; Respiratory function tests

Indexed keywords

FORMOTEROL; FORMOTEROL FUMARATE;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; BODY COMPOSITION; BODY MASS; BRONCHIECTASIS; BRONCHODILATATION; CHRONIC COUGH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INSPIRATORY CAPACITY; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PASSIVE SMOKING; SLOW VITAL CAPACITY; SMOKING; VITAL CAPACITY;

BRONCHIECTASIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 84876727493     PISSN: 08732159     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rppneu.2012.05.003     Document Type: Article

References (32)

1. Kohansal R., Martinez-Camblor P., Agustí A., Buist A.S., Mannino D.M., Soriano J.B. The natural history of chronic airflow obstruction revisited. An analysis of the Framingham offspring cohort. Am J Respir Crit Care Med 2009, 180:3-10.
2. Fletcher C., Peto R. The natural history of chronic airflow obstruction. Br Med J 1977, 1:1645-1648.
3. Rennard S.I., Vestbo J. COPD: the dangerous underestimate of 15%. Lancet 2006, 367:1216-1219.
4. Burrows B., Knudson R.J., Cline M.G., Lebowitz M.D. Quantitative relationships between cigarette smoking and ventilatory function. Am Rev Respir Dis 1977, 115:195-205.
5. Mannino D.M., Buist A.S., Petty T.L., Enright P.L. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003, 58:388-393.
6. Mannino D.M., Gagnon R.C., Petty T.L., Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000, 160:1683-1689.
7. Donaldson G.C., Seemungal T.A., Bhowmik A., Wedzicha J.A. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002, 57:847-852.
8. Vestbo J., Prescott E., Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity Copenhagen City Heart Study Group. Am J Respir Crit Care Med 1996, 153:1530-1535.
9. Postma D.S., Bruselle G., Bush A., Holloway J.W. I have taken my umbrella, so of course it does not rain. Thorax 2011, [Epub ahead of print].
10. Morrissey B.M. Pathogenesis of bronchiectasis. Clin Chest Med 2007, 28:289-296.
11. Cerveri I., Pellegrino R., Dore R., Corsico A., Fulgoni P., van de Woestijne K.P., et al. Mechanisms for isolated volume response to bronchodilator in patients with COPD. J Appl Physiol 2000, 88:1989-1995.
12. Schermer T., Heijdra Y., Zadel S., van den Bemt L., Boonman-de Winter L., Dekhuijzen R., et al. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD. Respir Med 2007, 101:1355-1362.
13. Walker P.P., Calverley P.M. The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease. COPD 2008, 5:147-152.
14. Jardim J.R., Oliveira J.A., Nascimento O. Consenso Brasileiro sobre Doença Pulmonar Obstrutiva Crônica. J Pneumol 2004, 30:S1-S42.
15. Pereira C.A.C., Neder J.A. Diretrizes para testes de função pulmonar. J Pneumol 2002, 28:S1-S238.
16. Crapo R.O., Casaburi R., Coates A.L., Enright P.L., MacIntyre N.R., McKay R.T., et al. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166:111-117.
17. Celli B.R., Cote C.G., Marin J.M., Casanova C., Montes de Oca M., Mendez R.A., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:1005-1012.
18. Pellegrino R., Viegi G., Brusasco V., Crapo R.O., Burgos F., Casaburi R., et al. Interpretative strategies for lung function tests. Eur Respir J 2005, 26:948-968.
19. Paré P.D., Lawson L.M., Brooks L.A. Patterns of response to inhaled bronchodilators in asthmatics. Am Rev Respir Dis 1983, 127:680-685.
20. Müller N.L., Fraser R.S., Colman N.C., Paré P.D. Métodos de investigação radiológica. Diagnóstico Radiológico das Doenças do Tórax 2003, 48-67. Guanabara Koogan S.A., Rio de Janeiro. N.L. Müller, R.S. Fraser, N.C. Colman, P.D. Paré (Eds.).
21. Roberts H.R., Wells A.U., Milne D.G., Rubens M.B., Kolbe J., Cole P.J., et al. Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests. Thorax 2000, 55:198-204.
22. Zieliñski J., Bednarek M. Early detection of COPD in a high-risk population using spirometric screening. Chest 2001, 119:731-736.
23. Siafakas N.M., Vermeire P., Pride N.B., Paoletti P., Gibson J., Howard P., et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 1995, 8:1398-1420.
24. Nishimura K., Izumi T., Tsukino M., Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002, 121:1434-1440.
25. Landbo C., Prescott E., Lange P., Vestbo J., Almdal T.P. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 160:1856-1861.
26. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., Hurd S.S. GOLD Scientific Committee Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001, 163:1256-1276.
27. Reid L.M. Reduction in bronchial subdivision in bronchiectasis. Thorax 1950, 5:233-247.
28. Hansell D.M., Wells A.U., Rubens M.B., Cole P.J. Bronchiectasis: functional significance of areas of decreased attenuation at expiratory CT. Radiology 1994, 193:369-374.
29. O'Brien C., Guest P.J., Hill S.L., Stockley R.A. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 2000, 55:635-642.
30. Patel I.S., Vlahos I., Wilkinson T.M.A., Lloyd-Owen S.J., Donaldson G.C., Wilks M., et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004, 170:400-407.
31. Wedzicha J.A. The heterogeneity of chronic obstructive pulmonary disease. Thorax 2000, 55:631-632.
32. Boucher R.C. Relationship of airway epithelial ion transport to chronic bronchitis. Proc Am Thorac Soc 2004, 1:66-70.